(PC) as it is highly expressed by malignant prostate cells.1,2 177Lu-DOTA-HuJ591-CHO (TLX591) is a radioimmunoconjugate comprised of the humanized IgG1 mAb rosopatamab, linked to the low energy beta-emitting radioisotope lutetium-177 (177Lu) via the bifunctional chelating agent DOTA-NHS ...
177Lu-DOTA-TLX591 safety, biodistribution and dosimetry study (ProstACT-SELECT)doi:10.1016/S2666-1683(22)02370-9K. O'ByrneD. MeyrickN. PatelF. FantinoC. HaywardElsevier B.V.European Urology Open Science